NCT07218003 2026-03-23A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Rondo TherapeuticsPhase 1 Enrolling by invitation149 enrolled
NCT04755517 2025-01-13HPV400Tampere University HospitalPhase NA Enrolling by invitation14,000 enrolled